Home » Tag Archives: FDA

Tag Archives: FDA

FDA Approves Bristol Myers Squibb’s New Antipsychotic Drug Cobenfy for Schizophrenia Treatment

The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride), for the treatment of schizophrenia, a chronic mental health disorder. Developed by Karuna Therapeutics and now owned by Bristol Myers Squibb, Cobenfy works by targeting cholinergic receptors unlike traditional antipsychotic medications that target dopamine receptors. This marks a significant departure from the conventional approach to schizophrenia treatment, according ...

Read More »

Obesity drug may decrease type 2 diabetes risk: Study reveals

Diabetes

New York, Sep 12 (IANS) The risk of type 2 diabetes is more than halved by weekly injections of the new obesity drug semaglutide, which was recently approved in the US and has been provisionally approved in England, says a new study. The researchers of the study, to be presented at the annual meeting of the European Association for the Study ...

Read More »
error: Content is protected !!